Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies
October 15, 2024 10:31 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA® (omadacycline) Across a Range of Serious Infections at IDWeek 2024
October 14, 2024 07:31 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA® (omadacycline) Across a Range of Serious Infections at IDWeek 2024
Pseudarthrosis Treatment Market is Projected to Reach $1.37 Billion at a CAGR 4.6% by 2034 | Fact.MR Report
September 05, 2024 06:00 ET
|
FACT.MR
Rockville, MD, Sept. 05, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, revenue from the global pseudarthrosis treatment market is estimated to reach US$ 879.4...
Antibiotics Strategic Business Report 2024: Rising Demand in Emerging Economies Accelerates Demand, Narrow-Spectrum Antibiotics Spurs Innovation in Targeted Therapy - Forecast to 2030
August 01, 2024 09:40 ET
|
Research and Markets
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Antibiotics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibiotics is...
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency Against Indicated Pathogens
July 31, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline)
Antibacterial Drugs Research - Global Strategic Business Report to 2030 Featuring Allergan, AstraZeneca, Bayer, BMS, GSK, Johnson & Johnson, Merck, Novartis, Pfizer,
July 26, 2024 06:27 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "Antibacterial Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antibacterial...
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® (omadacycline) for Patients with Moderate to Severe Community-Acquired Bacterial Pneumonia
July 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA®
Penicillin Drug Market Is Expected To Reach a Revenue Of USD 13.4 Bn By 2033, at 3.8% CAGR: Dimension Market Research
July 01, 2024 11:48 ET
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Penicillin Drug Market is predicted to reach a size of over USD 9.6 billion by 2024, and then it is expected to grow to more than USD...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
May 27, 2024 03:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Ampicillin Market Is Expected To Reach A Revenue Of USD 480.1 Mn By 2033, At 2.4% CAGR: Insights by Dimension Market Research
May 21, 2024 13:49 ET
|
Dimension Market Research
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Overview The Global Ampicillin Market size is expected to reach USD 388.1 million by 2024 and is further anticipated to reach USD 480.1 million by...